These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9470199)

  • 21. [Differentiated therapy of migraine attack].
    Skoromets AA; Amelin AV; Korenko LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):39. PubMed ID: 10629928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.
    Diener HC; Dowson AJ; Ferrari M; Nappi G; Tfelt-Hansen P
    Cephalalgia; 1999 Oct; 19(8):699-700. PubMed ID: 10570722
    [No Abstract]   [Full Text] [Related]  

  • 23. Increasing the options for effective migraine management.
    Goadsby PJ; Olesen J
    Neurology; 1997 Mar; 48(3 Suppl 3):S1-3. PubMed ID: 9071262
    [No Abstract]   [Full Text] [Related]  

  • 24. Extending therapeutic options? Prospects for the future.
    Edmeads JG
    Eur Neurol; 1996; 36 Suppl 2():32-3. PubMed ID: 8791031
    [No Abstract]   [Full Text] [Related]  

  • 25. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zolmitriptan provides effective migraine relief in adolescents.
    Linder SL; Dowson AJ
    Int J Clin Pract; 2000 Sep; 54(7):466-9. PubMed ID: 11070573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strong and sustained-acting triptan. Therewith migraine does not return soon].
    MMW Fortschr Med; 2003 Aug; 145(31-32):53. PubMed ID: 14524078
    [No Abstract]   [Full Text] [Related]  

  • 28. Is a central action of acute antimigraine drugs essential?
    Goadsby PJ
    Cephalalgia; 1997 Jun; 17 Suppl 17():10-1. PubMed ID: 9218879
    [No Abstract]   [Full Text] [Related]  

  • 29. [Zolmitriptan: new perspectives in migraine therapy. Satellite symposium of the 11th Migraine Trust International Symposium, London, 10 September 1996].
    Fortschr Neurol Psychiatr; 1997 Feb; 65(2 Suppl):1-4. PubMed ID: 9131063
    [No Abstract]   [Full Text] [Related]  

  • 30. Rizatriptan in the treatment of migraine.
    Dahlof CG; Rapoport AM; Sheftell FD; Lines CR
    Clin Ther; 1999 Nov; 21(11):1823-36; discussion 1821. PubMed ID: 10890255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract]   [Full Text] [Related]  

  • 32. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
    Burstein R; Collins B; Jakubowski M
    Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing migraine: sustained treatment, minimal time. Introduction.
    Postgrad Med; 2000 Sep; 108(3 Suppl):3. PubMed ID: 19667523
    [No Abstract]   [Full Text] [Related]  

  • 34. Rizatriptan. Convenience and consistency.
    Evans RW
    Postgrad Med; 2000 Sep; 108(3 Suppl):10-5. PubMed ID: 19667525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [First generic triptan approved].
    MMW Fortschr Med; 2006 Apr; 148(16):62-3. PubMed ID: 16688954
    [No Abstract]   [Full Text] [Related]  

  • 37. Measuring central action of acute antimigraine drugs in humans.
    Schoenen J
    Cephalalgia; 1997 Jun; 17 Suppl 17():12-5; discussion 15-6. PubMed ID: 9218880
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action.
    Martin GR
    Eur Neurol; 1996; 36 Suppl 2():13-8. PubMed ID: 8791027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabies vaccine approved.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470198
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA approves first drug in new class of antibiotics.
    Senior K
    Lancet; 2000 Apr; 355(9214):1523. PubMed ID: 10801180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.